Announced
Completed
Abu Dhabi Investment Authority and GIC led a $300m funding round in Taibang Biologic.
Synopsis
Sovereign wealth funds Abu Dhabi Investment Authority and GIC led a $300m funding round in Taibang Biologic, a biopharmaceutical firm. The proceeds will be used to finance its expansion of plasma stations and its research and development of new products.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.